• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗜酸性粒细胞与血小板比值作为慢性硬膜下血肿术后复发的预测指标

Eosinophil-Platelet Ratio as a Predictive Marker of the Postoperative Recurrence of a Chronic Subdural Hematoma.

作者信息

Yagi Kenji, Kanda Eiichiro, Hijikata Yasukazu, Tao Yoshifumi, Hishikawa Tomohito

机构信息

Department of Neurosurgery, Kawasaki Medical School, Kurashiki , Okayama , Japan.

Department of Medical Science, Kawasaki Medical School, Kurashiki , Okayama , Japan.

出版信息

Neurosurgery. 2025 Jun 1;96(6):1301-1306. doi: 10.1227/neu.0000000000003229. Epub 2024 Oct 11.

DOI:10.1227/neu.0000000000003229
PMID:39471081
Abstract

BACKGROUND AND OBJECTIVES

Symptomatic chronic subdural hematoma (CSDH) is caused by repetitive hemorrhage and inflammation, which is commonly treated with burr-hole surgery and has a relatively high postoperative recurrence rate. A decrease in the platelet count is indicative of a hemorrhagic tendency, while an increase in the eosinophil count is associated with inflammation. Assessing the balance between platelet-associated hemostasis and eosinophil-associated inflammation using the indeterminate biomarker, the eosinophil-platelet ratio (EPR), may be essential. Therefore, in this study, the accuracy of the EPR in predicting postoperative CSDH recurrence was evaluated and their correlation was determined.

METHODS

Data on symptomatic CSDHs of the cerebral hemisphere of patients who underwent burr-hole surgery at our institution between January 2013 and December 2022 were retrospectively reviewed. The EPR was calculated from preoperative peripheral blood examination data, and its correlation with postoperative CSDH recurrence was assessed. The hemispheres with CSDH were categorized into recurrence and nonrecurrence cohorts.

RESULTS

Data from 459 cerebral hemispheres of 405 patients with symptomatic CSDH were analyzed. In the 459 cerebral hemispheres with CSDH, 39 (8.5%) had postoperative recurrence. CSDH patients with a high EPR (≥1 × 10 -3 ) had a significantly higher recurrent rate than those with a low EPR (<1 × 10 -3 ) (15 of 86 [17.4%] vs 24 of 373 [6.4%], P = .002). In the modified Poisson regression analysis, the crude and adjusted risk ratios of high EPR were 2.79 (95% CI: 1.53, 5.09) and 2.62 (95% CI: 1.40, 4.89), respectively.

CONCLUSION

This study reveals that a high EPR is a useful predictive biomarker for postoperative CSDH recurrence. Cases of CSDH with a high EPR potentially require careful and close postoperative follow-up.

摘要

背景与目的

有症状的慢性硬膜下血肿(CSDH)由反复出血和炎症引起,通常采用钻孔手术治疗,术后复发率相对较高。血小板计数降低表明有出血倾向,而嗜酸性粒细胞计数增加与炎症相关。使用不确定生物标志物嗜酸性粒细胞 - 血小板比率(EPR)评估血小板相关止血与嗜酸性粒细胞相关炎症之间的平衡可能至关重要。因此,在本研究中,评估了EPR预测术后CSDH复发的准确性并确定了它们之间的相关性。

方法

回顾性分析2013年1月至2022年12月在我院接受钻孔手术的患者大脑半球有症状CSDH的数据。根据术前外周血检查数据计算EPR,并评估其与术后CSDH复发的相关性。将有CSDH的半球分为复发组和非复发组。

结果

分析了405例有症状CSDH患者的459个大脑半球的数据。在459个有CSDH的大脑半球中,39个(8.5%)术后复发。EPR高(≥1×10⁻³)的CSDH患者复发率明显高于EPR低(<1×10⁻³)的患者(86例中有15例[17.4%] vs 373例中有24例[6.4%],P = 0.002)。在修正的泊松回归分析中,高EPR的粗风险比和调整后风险比分别为2.79(95%CI:1.53,5.09)和2.62(95%CI:1.40,4.89)。

结论

本研究表明,高EPR是术后CSDH复发的有用预测生物标志物。EPR高的CSDH病例术后可能需要仔细密切随访。

相似文献

1
Eosinophil-Platelet Ratio as a Predictive Marker of the Postoperative Recurrence of a Chronic Subdural Hematoma.嗜酸性粒细胞与血小板比值作为慢性硬膜下血肿术后复发的预测指标
Neurosurgery. 2025 Jun 1;96(6):1301-1306. doi: 10.1227/neu.0000000000003229. Epub 2024 Oct 11.
2
Preoperative elevated eosinophils in peripheral blood for prediction of postoperative recurrence of chronic subdural hematoma.术前外周血嗜酸性粒细胞升高预测慢性硬脑膜下血肿术后复发。
J Neurosurg. 2023 Jan 13;139(3):708-713. doi: 10.3171/2022.12.JNS222432. Print 2023 Sep 1.
3
Effect of decreased platelets on postoperative recurrence of chronic subdural hematoma.血小板减少对慢性硬膜下血肿术后复发的影响。
Front Neurol. 2023 Dec 20;14:1308991. doi: 10.3389/fneur.2023.1308991. eCollection 2023.
4
Double-crescent sign as a predictor of chronic subdural hematoma recurrence following burr-hole surgery.双月牙征可预测颅骨钻孔术后慢性硬膜下血肿复发。
J Neurosurg. 2019 Jan 4;131(6):1905-1911. doi: 10.3171/2018.8.JNS18805. Print 2019 Dec 1.
5
Peripheral blood eosinophil and classification of residual hematoma help predict the recurrence of chronic subdural hematoma after initial surgery.外周血嗜酸性粒细胞及残余血肿分级有助于预测慢性硬膜下血肿初次手术后的复发情况。
Front Surg. 2022 Sep 23;9:970468. doi: 10.3389/fsurg.2022.970468. eCollection 2022.
6
Prediction of Postoperative Recurrence of Chronic Subdural Hematoma Using Preoperative Systemic Immune Inflammation Index and Eosinophils.利用术前全身免疫炎症指数和嗜酸性粒细胞预测慢性硬膜下血肿术后复发
Asian J Neurosurg. 2024 Aug 21;19(4):707-714. doi: 10.1055/s-0044-1789247. eCollection 2024 Dec.
7
Postoperative recurrence of chronic subdural hematoma is more frequent in patients with blood type A.慢性硬膜下血肿术后复发在A型血患者中更为常见。
J Neurosurg. 2021 Jan 1;135(4):1203-1207. doi: 10.3171/2020.7.JNS202330. Print 2021 Oct 1.
8
Postoperative neutrophil-to-lymphocyte ratio variation is associated with chronic subdural hematoma recurrence.术后中性粒细胞与淋巴细胞比值的变化与慢性硬膜下血肿复发相关。
Neurol Sci. 2022 Jan;43(1):427-434. doi: 10.1007/s10072-021-05241-y. Epub 2021 Apr 23.
9
Predictors of acute intracranial hemorrhage and recurrence of chronic subdural hematoma following burr hole drainage.颅骨钻孔引流术后急性颅内出血和慢性硬膜下血肿复发的预测因素。
BMC Neurol. 2020 Mar 13;20(1):92. doi: 10.1186/s12883-020-01669-5.
10
The efficacy and safety of burr-hole craniotomy without continuous drainage for chronic subdural hematoma and subdural hygroma in children under 2 years of age.2岁以下儿童慢性硬膜下血肿和硬膜下积液行钻孔开颅术不持续引流的疗效及安全性
Childs Nerv Syst. 2016 Dec;32(12):2369-2375. doi: 10.1007/s00381-016-3233-9. Epub 2016 Sep 9.

引用本文的文献

1
Contralateral Progression after Unilateral Surgery for Bilateral Chronic Subdural Hematoma: A Prospective Observational Study.双侧慢性硬膜下血肿单侧手术后的对侧进展:一项前瞻性观察研究。
Neurol Med Chir (Tokyo). 2025 Apr 15;65(4):195-202. doi: 10.2176/jns-nmc.2024-0308. Epub 2025 Mar 21.